Richard N. Levy, Director at UNIGENE LABORATORIES INC (UGNE), bought 150,000 shares at $0.75 ($112K) on 2010-12-20, disclosed to the SEC on 2010-12-22.
Open-market purchase of $112k UGNE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.75 | 50,000 | $38K | 33.5% |
| 2 | $0.75 | 50,000 | $38K | 33.5% |
| 3 | $0.74 | 50,000 | $37K | 33.0% |
| Total | $0.75 avg | 150,000 | $112K | 100% |
| Filing → |
| BKKT | SELL | 2023-12-20 | $956K | — | Filing → |
| BKKT | SELL | 2023-12-19 | $581K | — | Filing → |
| BKKT | SELL | 2023-12-06 | $165K | — | Filing → |